The Lancet HIV in conversation with

Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.

Listen on:

Episodes

Nov 7, 2022

29 min

Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV.Read the PopART trial papers:Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) communityImpact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South AfricaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Nov 7, 2022

29 min

Sep 28, 2022

17 min

Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex.Read the full Review:HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with menContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Sep 28, 2022

17 min

Aug 31, 2022

21 min

Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda.Read the full article:A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in UgandaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Aug 31, 2022

21 min

Jul 27, 2022

13 min

Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B. Read the full article:Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis BContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Jul 27, 2022

13 min

Jul 1, 2022

13 min

Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing.Read the full article:Efficiency of 6-month PrEP dispensing with HIV self-testing in KenyaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Jul 1, 2022

13 min

Jun 1, 2022

22 min

Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine.Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Jun 1, 2022

22 min

May 3, 2022

20 min

Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV. Read the full article:Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trialContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

May 3, 2022

20 min

Mar 2, 2022

15 min

Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV.Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Mar 2, 2022

15 min

Feb 24, 2022

15 min

Dr Amy Justice (Yale University, USA) talks to Philippa Harris about the joint The Lancet HIV and The Lancet Healthy Longevity Series Ageing with HIV.Read the Series:Ageing with HIVContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Feb 24, 2022

15 min

Feb 2, 2022

14 min

Peter Hayward talks to Dr Bridget Mugisa (WHO, Eastern Mediterranean Office, Egypt) about a study summarising the epidemiology of HIV in the Middle East and north Africa. Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Feb 2, 2022

14 min

© 2026 The Lancet Group

Podcast Powered By Podbean

Version: 20241125